0.00Open0.00Pre Close0 Volume0 Open Interest50.00Strike Price0.00Turnover0.00%IV39.07%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma36.47Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AZZ Inc Stock Discussion
In reaction to earnings/guidance:
• $New Relic (NEWR.US)$ +3.8% (guidance), $American Airlines (AAL.US)$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC. (DICE.US)$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma (ALBO.US)$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
- $Consolidated Communications (CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $Voyager Therapeutics (VYGR.US)$ +12.2%: agrees to licensing option with $Novartis AG (NVS.US)$; Voyager receives $54 million upfront.
- $Aegon Ltd (AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $AZZ Inc (AZZ.US)$ +...
No comment yet